Paul Grootendorst

Data for paper Intellectual property protection and drug plan coverage: evidence from Ontario. January 2018
(download article in XLS format)
Trends in medical cannabis use in Canada, 2001-2016
With Igor Korolija, Minsup Shim; November 2017
(download article in PDF format)

Uptake and impact of licensed pharmacy technicians in Ontario community pharmacies
With Minsup Shim, Jimmy Tieu; June 19, 2017
(download article in PDF format)

Intellectual Property Protection and Drug Plan Coverage: Evidence From Ontario
With Minsup Shim, Adam Falconi, Tyler Robinson, Ethar Ismail, Joel Lexchin; May 4, 2015.
http://www.canadiancentreforhealtheconomics.ca/papers/intellectual-property-protection-and-drug-plan-coverage-evidence-from-ontario/

A comparison of mechanisms for setting generic drug prices
With Aidan Hollis; March 11, 2013.
(download article in PDF format)

Health Technologies as a Cost-Driver in Canada
With Hai Nguyen, Alexandra Constant, MS Shim; June 2011.
(download article in PDF format)

Managing pharmaceutical expenditure: Overview and options for Canada
With Aidan Hollis; February 18, 2011
(download article in PDF format)

Economic Policy, Obesity and Health: A Scoping Review
With Faulkner G, Nguyen VH, Ferrence R, Mendelson R, Donnelly P, Arbour-Nicitopoulos K.; July 2010
(download article in PDF format)

An economic analysis of the impact of reductions in generic drug rebates on community pharmacy in Canada
With Marie Rocchi, Harold Segal; Research Assistants: Chakshu Gupta, MS Shim; November 21, 2008
(download article in PDF format)

Effects of ‘authorized generics’ on Canadian drug prices. SEDAP Research Paper No. 201. Also appears in: Marcel Boyer, Michael Trebilcock and David Vaver, eds. Competition Policy and Intellectual Property. Toronto: Irwin Law Inc., 2009.
http://socserv.mcmaster.ca/sedap/p/sedap201.pdf

Distributional Effects of “Needs-Based” Drug Subsidies: Regional Evidence from Canada
With Jeffrey S. Racine; June 29, 2006
(download article in PDF format)

The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes. Vol I: Summary.
With L Dolovich, A Holbrook, A Levy, B O'Brien; Revised October 4, 2001
(download article in PDF format)

The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes.Vol II: Technical Report.
With L Dolovich, A Holbrook, A Levy, B O'Brien; Revised October 4, 2001
(download article in PDF format)

The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes.Vol III: ACECCB Literature Review.
With L Dolovich, A Holbrook, A Levy, B O'Brien; Revised October 4, 2001
(download article in PDF format)